Mapping SCA1 regional vulnerabilities reveals neural and skeletal muscle contributions to disease

Spinocerebellar ataxia type 1 (SCA1) is a fatal neurodegenerative disease caused by an expanded polyglutamine tract in the widely expressed ataxin-1 (ATXN1) protein. To elucidate anatomical regions and cell types that underlie mutant ATXN1-induced disease phenotypes, we developed a floxed conditiona...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JCI insight 2024-05, Vol.9 (9)
Hauptverfasser: Duvick, Lisa, Southern, W Michael, Benzow, Kellie A, Burch, Zoe N, Handler, Hillary P, Mitchell, Jason S, Kuivinen, Hannah, Gadiparthi, Udaya, Yang, Praseuth, Soles, Alyssa, Sheeler, Carrie A, Rainwater, Orion, Serres, Shannah, Lind, Erin B, Nichols-Meade, Tessa, You, Yun, O'Callaghan, Brennon, Zoghbi, Huda Y, Cvetanovic, Marija, Wheeler, Vanessa C, Ervasti, James M, Koob, Michael D, Orr, Harry T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 9
container_start_page
container_title JCI insight
container_volume 9
creator Duvick, Lisa
Southern, W Michael
Benzow, Kellie A
Burch, Zoe N
Handler, Hillary P
Mitchell, Jason S
Kuivinen, Hannah
Gadiparthi, Udaya
Yang, Praseuth
Soles, Alyssa
Sheeler, Carrie A
Rainwater, Orion
Serres, Shannah
Lind, Erin B
Nichols-Meade, Tessa
You, Yun
O'Callaghan, Brennon
Zoghbi, Huda Y
Cvetanovic, Marija
Wheeler, Vanessa C
Ervasti, James M
Koob, Michael D
Orr, Harry T
description Spinocerebellar ataxia type 1 (SCA1) is a fatal neurodegenerative disease caused by an expanded polyglutamine tract in the widely expressed ataxin-1 (ATXN1) protein. To elucidate anatomical regions and cell types that underlie mutant ATXN1-induced disease phenotypes, we developed a floxed conditional knockin mouse (f-ATXN1146Q/2Q) with mouse Atxn1 coding exons replaced by human ATXN1 exons encoding 146 glutamines. f-ATXN1146Q/2Q mice manifested SCA1-like phenotypes including motor and cognitive deficits, wasting, and decreased survival. Central nervous system (CNS) contributions to disease were revealed using f-ATXN1146Q/2Q;Nestin-Cre mice, which showed improved rotarod, open field, and Barnes maze performance by 6-12 weeks of age. In contrast, striatal contributions to motor deficits using f-ATXN1146Q/2Q;Rgs9-Cre mice revealed that mice lacking ATXN1146Q/2Q in striatal medium-spiny neurons showed a trending improvement in rotarod performance at 30 weeks of age. Surprisingly, a prominent role for muscle contributions to disease was revealed in f-ATXN1146Q/2Q;ACTA1-Cre mice based on their recovery from kyphosis and absence of muscle pathology. Collectively, data from the targeted conditional deletion of the expanded allele demonstrated CNS and peripheral contributions to disease and highlighted the need to consider muscle in addition to the brain for optimal SCA1 therapeutics.
doi_str_mv 10.1172/jci.insight.176057
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2974006344</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2974006344</sourcerecordid><originalsourceid>FETCH-LOGICAL-c298t-751d383a305b7692ffcecfc8eb22bb9107424155f59972260e0424f57858dbcd3</originalsourceid><addsrcrecordid>eNpNkEtLAzEUhYMottT-ARcySzeteUwmmWUpvqDiQl2HJHOnps7LJFPw3xtpFVf3ce45XD6ELgleEiLozc66peuC277HJREF5uIETSkT5YIJLE__9RM0D2GHMSYip5jLczRhkhOas3yK9JMeBtdts5f1imQetq7vdJPtx6YDr41rXHQQkrAH3YSsg9EnWXdVFj6ggZiGdgy2gcz2XfTOjDElhCz2WeUC6AAX6KxOVpgf6wy93d2-rh8Wm-f7x_Vqs7C0lHEhOKmYZJphbkRR0rq2YGsrwVBqTElwej4nnNe8LAWlBQacFjUXksvK2IrN0PUhd_D95wghqtYFC02jO-jHoGgpcowLlufplB5Ore9D8FCrwbtW-y9FsPqhqxJddaSrDnST6eqYP5oWqj_LL0v2DVnseUs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2974006344</pqid></control><display><type>article</type><title>Mapping SCA1 regional vulnerabilities reveals neural and skeletal muscle contributions to disease</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Duvick, Lisa ; Southern, W Michael ; Benzow, Kellie A ; Burch, Zoe N ; Handler, Hillary P ; Mitchell, Jason S ; Kuivinen, Hannah ; Gadiparthi, Udaya ; Yang, Praseuth ; Soles, Alyssa ; Sheeler, Carrie A ; Rainwater, Orion ; Serres, Shannah ; Lind, Erin B ; Nichols-Meade, Tessa ; You, Yun ; O'Callaghan, Brennon ; Zoghbi, Huda Y ; Cvetanovic, Marija ; Wheeler, Vanessa C ; Ervasti, James M ; Koob, Michael D ; Orr, Harry T</creator><creatorcontrib>Duvick, Lisa ; Southern, W Michael ; Benzow, Kellie A ; Burch, Zoe N ; Handler, Hillary P ; Mitchell, Jason S ; Kuivinen, Hannah ; Gadiparthi, Udaya ; Yang, Praseuth ; Soles, Alyssa ; Sheeler, Carrie A ; Rainwater, Orion ; Serres, Shannah ; Lind, Erin B ; Nichols-Meade, Tessa ; You, Yun ; O'Callaghan, Brennon ; Zoghbi, Huda Y ; Cvetanovic, Marija ; Wheeler, Vanessa C ; Ervasti, James M ; Koob, Michael D ; Orr, Harry T</creatorcontrib><description>Spinocerebellar ataxia type 1 (SCA1) is a fatal neurodegenerative disease caused by an expanded polyglutamine tract in the widely expressed ataxin-1 (ATXN1) protein. To elucidate anatomical regions and cell types that underlie mutant ATXN1-induced disease phenotypes, we developed a floxed conditional knockin mouse (f-ATXN1146Q/2Q) with mouse Atxn1 coding exons replaced by human ATXN1 exons encoding 146 glutamines. f-ATXN1146Q/2Q mice manifested SCA1-like phenotypes including motor and cognitive deficits, wasting, and decreased survival. Central nervous system (CNS) contributions to disease were revealed using f-ATXN1146Q/2Q;Nestin-Cre mice, which showed improved rotarod, open field, and Barnes maze performance by 6-12 weeks of age. In contrast, striatal contributions to motor deficits using f-ATXN1146Q/2Q;Rgs9-Cre mice revealed that mice lacking ATXN1146Q/2Q in striatal medium-spiny neurons showed a trending improvement in rotarod performance at 30 weeks of age. Surprisingly, a prominent role for muscle contributions to disease was revealed in f-ATXN1146Q/2Q;ACTA1-Cre mice based on their recovery from kyphosis and absence of muscle pathology. Collectively, data from the targeted conditional deletion of the expanded allele demonstrated CNS and peripheral contributions to disease and highlighted the need to consider muscle in addition to the brain for optimal SCA1 therapeutics.</description><identifier>ISSN: 2379-3708</identifier><identifier>EISSN: 2379-3708</identifier><identifier>DOI: 10.1172/jci.insight.176057</identifier><identifier>PMID: 38512434</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Ataxin-1 - genetics ; Ataxin-1 - metabolism ; Disease Models, Animal ; Female ; Gene Knock-In Techniques ; Humans ; Male ; Mice ; Mice, Transgenic ; Muscle, Skeletal - metabolism ; Muscle, Skeletal - pathology ; Neurons - metabolism ; Neurons - pathology ; Phenotype ; Spinocerebellar Ataxias - genetics ; Spinocerebellar Ataxias - pathology</subject><ispartof>JCI insight, 2024-05, Vol.9 (9)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c298t-751d383a305b7692ffcecfc8eb22bb9107424155f59972260e0424f57858dbcd3</cites><orcidid>0000-0002-0700-3349 ; 0000-0002-0292-7614 ; 0000-0001-6118-741X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38512434$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Duvick, Lisa</creatorcontrib><creatorcontrib>Southern, W Michael</creatorcontrib><creatorcontrib>Benzow, Kellie A</creatorcontrib><creatorcontrib>Burch, Zoe N</creatorcontrib><creatorcontrib>Handler, Hillary P</creatorcontrib><creatorcontrib>Mitchell, Jason S</creatorcontrib><creatorcontrib>Kuivinen, Hannah</creatorcontrib><creatorcontrib>Gadiparthi, Udaya</creatorcontrib><creatorcontrib>Yang, Praseuth</creatorcontrib><creatorcontrib>Soles, Alyssa</creatorcontrib><creatorcontrib>Sheeler, Carrie A</creatorcontrib><creatorcontrib>Rainwater, Orion</creatorcontrib><creatorcontrib>Serres, Shannah</creatorcontrib><creatorcontrib>Lind, Erin B</creatorcontrib><creatorcontrib>Nichols-Meade, Tessa</creatorcontrib><creatorcontrib>You, Yun</creatorcontrib><creatorcontrib>O'Callaghan, Brennon</creatorcontrib><creatorcontrib>Zoghbi, Huda Y</creatorcontrib><creatorcontrib>Cvetanovic, Marija</creatorcontrib><creatorcontrib>Wheeler, Vanessa C</creatorcontrib><creatorcontrib>Ervasti, James M</creatorcontrib><creatorcontrib>Koob, Michael D</creatorcontrib><creatorcontrib>Orr, Harry T</creatorcontrib><title>Mapping SCA1 regional vulnerabilities reveals neural and skeletal muscle contributions to disease</title><title>JCI insight</title><addtitle>JCI Insight</addtitle><description>Spinocerebellar ataxia type 1 (SCA1) is a fatal neurodegenerative disease caused by an expanded polyglutamine tract in the widely expressed ataxin-1 (ATXN1) protein. To elucidate anatomical regions and cell types that underlie mutant ATXN1-induced disease phenotypes, we developed a floxed conditional knockin mouse (f-ATXN1146Q/2Q) with mouse Atxn1 coding exons replaced by human ATXN1 exons encoding 146 glutamines. f-ATXN1146Q/2Q mice manifested SCA1-like phenotypes including motor and cognitive deficits, wasting, and decreased survival. Central nervous system (CNS) contributions to disease were revealed using f-ATXN1146Q/2Q;Nestin-Cre mice, which showed improved rotarod, open field, and Barnes maze performance by 6-12 weeks of age. In contrast, striatal contributions to motor deficits using f-ATXN1146Q/2Q;Rgs9-Cre mice revealed that mice lacking ATXN1146Q/2Q in striatal medium-spiny neurons showed a trending improvement in rotarod performance at 30 weeks of age. Surprisingly, a prominent role for muscle contributions to disease was revealed in f-ATXN1146Q/2Q;ACTA1-Cre mice based on their recovery from kyphosis and absence of muscle pathology. Collectively, data from the targeted conditional deletion of the expanded allele demonstrated CNS and peripheral contributions to disease and highlighted the need to consider muscle in addition to the brain for optimal SCA1 therapeutics.</description><subject>Animals</subject><subject>Ataxin-1 - genetics</subject><subject>Ataxin-1 - metabolism</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Gene Knock-In Techniques</subject><subject>Humans</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Muscle, Skeletal - metabolism</subject><subject>Muscle, Skeletal - pathology</subject><subject>Neurons - metabolism</subject><subject>Neurons - pathology</subject><subject>Phenotype</subject><subject>Spinocerebellar Ataxias - genetics</subject><subject>Spinocerebellar Ataxias - pathology</subject><issn>2379-3708</issn><issn>2379-3708</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkEtLAzEUhYMottT-ARcySzeteUwmmWUpvqDiQl2HJHOnps7LJFPw3xtpFVf3ce45XD6ELgleEiLozc66peuC277HJREF5uIETSkT5YIJLE__9RM0D2GHMSYip5jLczRhkhOas3yK9JMeBtdts5f1imQetq7vdJPtx6YDr41rXHQQkrAH3YSsg9EnWXdVFj6ggZiGdgy2gcz2XfTOjDElhCz2WeUC6AAX6KxOVpgf6wy93d2-rh8Wm-f7x_Vqs7C0lHEhOKmYZJphbkRR0rq2YGsrwVBqTElwej4nnNe8LAWlBQacFjUXksvK2IrN0PUhd_D95wghqtYFC02jO-jHoGgpcowLlufplB5Ore9D8FCrwbtW-y9FsPqhqxJddaSrDnST6eqYP5oWqj_LL0v2DVnseUs</recordid><startdate>20240508</startdate><enddate>20240508</enddate><creator>Duvick, Lisa</creator><creator>Southern, W Michael</creator><creator>Benzow, Kellie A</creator><creator>Burch, Zoe N</creator><creator>Handler, Hillary P</creator><creator>Mitchell, Jason S</creator><creator>Kuivinen, Hannah</creator><creator>Gadiparthi, Udaya</creator><creator>Yang, Praseuth</creator><creator>Soles, Alyssa</creator><creator>Sheeler, Carrie A</creator><creator>Rainwater, Orion</creator><creator>Serres, Shannah</creator><creator>Lind, Erin B</creator><creator>Nichols-Meade, Tessa</creator><creator>You, Yun</creator><creator>O'Callaghan, Brennon</creator><creator>Zoghbi, Huda Y</creator><creator>Cvetanovic, Marija</creator><creator>Wheeler, Vanessa C</creator><creator>Ervasti, James M</creator><creator>Koob, Michael D</creator><creator>Orr, Harry T</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0700-3349</orcidid><orcidid>https://orcid.org/0000-0002-0292-7614</orcidid><orcidid>https://orcid.org/0000-0001-6118-741X</orcidid></search><sort><creationdate>20240508</creationdate><title>Mapping SCA1 regional vulnerabilities reveals neural and skeletal muscle contributions to disease</title><author>Duvick, Lisa ; Southern, W Michael ; Benzow, Kellie A ; Burch, Zoe N ; Handler, Hillary P ; Mitchell, Jason S ; Kuivinen, Hannah ; Gadiparthi, Udaya ; Yang, Praseuth ; Soles, Alyssa ; Sheeler, Carrie A ; Rainwater, Orion ; Serres, Shannah ; Lind, Erin B ; Nichols-Meade, Tessa ; You, Yun ; O'Callaghan, Brennon ; Zoghbi, Huda Y ; Cvetanovic, Marija ; Wheeler, Vanessa C ; Ervasti, James M ; Koob, Michael D ; Orr, Harry T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c298t-751d383a305b7692ffcecfc8eb22bb9107424155f59972260e0424f57858dbcd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Ataxin-1 - genetics</topic><topic>Ataxin-1 - metabolism</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Gene Knock-In Techniques</topic><topic>Humans</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Muscle, Skeletal - metabolism</topic><topic>Muscle, Skeletal - pathology</topic><topic>Neurons - metabolism</topic><topic>Neurons - pathology</topic><topic>Phenotype</topic><topic>Spinocerebellar Ataxias - genetics</topic><topic>Spinocerebellar Ataxias - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Duvick, Lisa</creatorcontrib><creatorcontrib>Southern, W Michael</creatorcontrib><creatorcontrib>Benzow, Kellie A</creatorcontrib><creatorcontrib>Burch, Zoe N</creatorcontrib><creatorcontrib>Handler, Hillary P</creatorcontrib><creatorcontrib>Mitchell, Jason S</creatorcontrib><creatorcontrib>Kuivinen, Hannah</creatorcontrib><creatorcontrib>Gadiparthi, Udaya</creatorcontrib><creatorcontrib>Yang, Praseuth</creatorcontrib><creatorcontrib>Soles, Alyssa</creatorcontrib><creatorcontrib>Sheeler, Carrie A</creatorcontrib><creatorcontrib>Rainwater, Orion</creatorcontrib><creatorcontrib>Serres, Shannah</creatorcontrib><creatorcontrib>Lind, Erin B</creatorcontrib><creatorcontrib>Nichols-Meade, Tessa</creatorcontrib><creatorcontrib>You, Yun</creatorcontrib><creatorcontrib>O'Callaghan, Brennon</creatorcontrib><creatorcontrib>Zoghbi, Huda Y</creatorcontrib><creatorcontrib>Cvetanovic, Marija</creatorcontrib><creatorcontrib>Wheeler, Vanessa C</creatorcontrib><creatorcontrib>Ervasti, James M</creatorcontrib><creatorcontrib>Koob, Michael D</creatorcontrib><creatorcontrib>Orr, Harry T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>JCI insight</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duvick, Lisa</au><au>Southern, W Michael</au><au>Benzow, Kellie A</au><au>Burch, Zoe N</au><au>Handler, Hillary P</au><au>Mitchell, Jason S</au><au>Kuivinen, Hannah</au><au>Gadiparthi, Udaya</au><au>Yang, Praseuth</au><au>Soles, Alyssa</au><au>Sheeler, Carrie A</au><au>Rainwater, Orion</au><au>Serres, Shannah</au><au>Lind, Erin B</au><au>Nichols-Meade, Tessa</au><au>You, Yun</au><au>O'Callaghan, Brennon</au><au>Zoghbi, Huda Y</au><au>Cvetanovic, Marija</au><au>Wheeler, Vanessa C</au><au>Ervasti, James M</au><au>Koob, Michael D</au><au>Orr, Harry T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mapping SCA1 regional vulnerabilities reveals neural and skeletal muscle contributions to disease</atitle><jtitle>JCI insight</jtitle><addtitle>JCI Insight</addtitle><date>2024-05-08</date><risdate>2024</risdate><volume>9</volume><issue>9</issue><issn>2379-3708</issn><eissn>2379-3708</eissn><abstract>Spinocerebellar ataxia type 1 (SCA1) is a fatal neurodegenerative disease caused by an expanded polyglutamine tract in the widely expressed ataxin-1 (ATXN1) protein. To elucidate anatomical regions and cell types that underlie mutant ATXN1-induced disease phenotypes, we developed a floxed conditional knockin mouse (f-ATXN1146Q/2Q) with mouse Atxn1 coding exons replaced by human ATXN1 exons encoding 146 glutamines. f-ATXN1146Q/2Q mice manifested SCA1-like phenotypes including motor and cognitive deficits, wasting, and decreased survival. Central nervous system (CNS) contributions to disease were revealed using f-ATXN1146Q/2Q;Nestin-Cre mice, which showed improved rotarod, open field, and Barnes maze performance by 6-12 weeks of age. In contrast, striatal contributions to motor deficits using f-ATXN1146Q/2Q;Rgs9-Cre mice revealed that mice lacking ATXN1146Q/2Q in striatal medium-spiny neurons showed a trending improvement in rotarod performance at 30 weeks of age. Surprisingly, a prominent role for muscle contributions to disease was revealed in f-ATXN1146Q/2Q;ACTA1-Cre mice based on their recovery from kyphosis and absence of muscle pathology. Collectively, data from the targeted conditional deletion of the expanded allele demonstrated CNS and peripheral contributions to disease and highlighted the need to consider muscle in addition to the brain for optimal SCA1 therapeutics.</abstract><cop>United States</cop><pmid>38512434</pmid><doi>10.1172/jci.insight.176057</doi><orcidid>https://orcid.org/0000-0002-0700-3349</orcidid><orcidid>https://orcid.org/0000-0002-0292-7614</orcidid><orcidid>https://orcid.org/0000-0001-6118-741X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2379-3708
ispartof JCI insight, 2024-05, Vol.9 (9)
issn 2379-3708
2379-3708
language eng
recordid cdi_proquest_miscellaneous_2974006344
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Animals
Ataxin-1 - genetics
Ataxin-1 - metabolism
Disease Models, Animal
Female
Gene Knock-In Techniques
Humans
Male
Mice
Mice, Transgenic
Muscle, Skeletal - metabolism
Muscle, Skeletal - pathology
Neurons - metabolism
Neurons - pathology
Phenotype
Spinocerebellar Ataxias - genetics
Spinocerebellar Ataxias - pathology
title Mapping SCA1 regional vulnerabilities reveals neural and skeletal muscle contributions to disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T05%3A53%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mapping%20SCA1%20regional%20vulnerabilities%20reveals%20neural%20and%20skeletal%20muscle%20contributions%20to%20disease&rft.jtitle=JCI%20insight&rft.au=Duvick,%20Lisa&rft.date=2024-05-08&rft.volume=9&rft.issue=9&rft.issn=2379-3708&rft.eissn=2379-3708&rft_id=info:doi/10.1172/jci.insight.176057&rft_dat=%3Cproquest_cross%3E2974006344%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2974006344&rft_id=info:pmid/38512434&rfr_iscdi=true